Chemours Reports $381 Million Net Loss in Q2 2025 Amid Rising Sales and Costs

The Chemours Company reported a net loss of $381 million for the second quarter of 2025, a significant decline compared to a net income of $60 million in the same period of 2024. For the first half of 2025, the company recorded a net loss of $385 million, down from a profit of $113 million in the prior year. The losses translated to a basic loss per share of $2.54 for the second quarter and $2.56 for the first half, compared to earnings per share of $0.40 and $0.76, respectively, in 2024. The company's total net sales increased to $1.615 billion for the second quarter, up 4% from $1.554 billion a year earlier, and reached $2.983 billion for the first half, a 2% increase from $2.915 billion.

The increase in net sales was primarily driven by a 3% rise in sales volume, particularly in the Thermal & Specialized Solutions segment, which saw a notable demand for Opteon™ refrigerants. However, the company faced challenges with rising costs, as the cost of goods sold rose to $1.337 billion in the second quarter, up from $1.246 billion in 2024. Selling, general, and administrative expenses surged to $437 million, more than doubling from $154 million in the previous year, largely due to litigation-related charges associated with a settlement agreement with the State of New Jersey.

Chemours has been actively restructuring its operations, including the exit from its SPS Capstone™ business, which resulted in restructuring charges of $18 million for the second quarter and $51 million for the first half of 2025. The company also reported a decrease in equity earnings from affiliates, which fell to $9 million for the second quarter, down from $11 million in 2024, reflecting lower demand in the regions where its investees operate.

Looking ahead, Chemours anticipates continued challenges, particularly from ongoing litigation and environmental remediation costs. The company has accrued $605 million for environmental remediation liabilities as of June 30, 2025, with $102 million classified as current liabilities. The company expects to meet its cash needs through operational cash flows and has $502 million in unrestricted cash and cash equivalents, along with $954 million available under its revolving credit facility. Chemours remains committed to its sustainability goals and is focused on managing its environmental impact while navigating the complexities of regulatory compliance and market conditions.